Found 0 matching trials
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies PHASE2 Patients less than or equal to 21 years old with high-risk hematologic mali...
Show More Status
Active Not Recruiting
Location
St. Jude Children's Research Hospital
Learn More & Join Trial
UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia PHASE2 Allogeneic hematopoietic stem cell transplantation is a life-saving procedu...
Show More Status
Active Not Recruiting
Location
CIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemont
Learn More & Join Trial
Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device NA T cell depletion utilizing the CliniMACS device will allow more precise, sp...
Show More Location
Children's Hospital of Wisconsin
Learn More & Join Trial
Combination Chemotherapy in Treating Patients With Lymphoma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
University of Texas - MD Anderson Cancer Center
Learn More & Join Trial
Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor PHASE2 The purpose of this study is to determine whether the administration of a d...
Show More Location
Ohio State University, Comprehesive Cancer Center
Learn More & Join Trial
Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants N/A The objective of this study is to make T-cell depleted stem cells from a fa...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy. PHASE1 Given the poor prognosis of HIV-associated non-Hodgkin's lymphoma (NHL) and...
Show More Location
Servide d'Immunologie Clinique
Learn More & Join Trial
Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer PHASE1 This study will evaluate the effectiveness of combination chemotherapy with...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders PHASE2 The purpose of this study is to investigate the safety and efficacy of TCRα...
Show More Location
Cincinnati Children's Hospital Medical Center
Learn More & Join Trial
Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation N/A Allogeneic hematopoietic stem cell transplantation (HSCT) is an established...
Show More Status
No Longer Available
Location
Emory University/Winship Cancer Institute
Learn More & Join Trial